OR WAIT null SECS
“[BPH treatment] has to be individualized to the motivations of the patient, and also what I call his "phenotype.” How big is his prostate? How bad is this problem? And what is his tolerance for side effects?” says Kevin T. McVary, MD.
In this video, Kevin McVary, MD, FACS, discusses his patient selection process for BPH clinical trials and the importance of individualized care. McVary is a professor of urology and director of the Center for Male Health at Loyola University Medical Center, Maywood, Illinois.